Recent works have shown that the loss of CD28 expression is a hallmark of senescent CD8+ T cells, and proportion changes in CD8+CD28− cells have been reported in aging-related diseases such as cancer, cardiovascular disease, and other chronic inflammatory diseases (17–19). The gene discussed is CD8A; the disease is cancer.